Author

Floyd Hassenrueck

Murdoch Children's Research Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Alexander MaytumiD· 1 shared Andrew G. ElefantyiD· 1 shared Constanze BoniferiD· 1 shared Edouard G. StanleyiD· 1 shared Elizabeth NgiD· 1 shared Katerina Terolli· 1 shared Léa FlippeiD· 1 shared Peter KeaneiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexander MaytumORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The ratio of RUNX1-ETO oncoprotein to normal RUNX1 expression determines the balance between endothelial reprogramming and hematopoietic cell growth

Floyd Hassenrueck, Katerina Terolli, Alexander Maytum, Peter Keane, Léa Flippe, Sophie G. Kellaway, Edouard G. Stanley, Elizabeth Ng, Andrew G. Elefanty, Constanze Bonifer

The study shows that RUNX1-ETO levels determine endothelial reprogramming and hematopoietic cell growth in AML by altering the balance between these processes.

bioRxiv · Dec 23, 2025 · PreprintCancer Biology